On Thursday 13th February 2020, NHS England’s annual infection-prevention and control conference will take place at the National Conference Centre, Birmingham. High on the agenda will be the latest strategies to tackle the burden of healthcare-associated infection, against a backdrop of rising antimicrobial resistance.
NHS medical and management professionals are making major progress in the constant battle to prevent and control healthcareassociated infection (HCAI). But there is still much to do, with latest infection-figures (for 2018/19) revealing 83,000 cases of E. coli, Klebsiella spp., P. aeruginosa, MRSA and MSSA bacteraemia, and CDI, affecting 73,000 patients, across England – resulting in more than 12,700 patient deaths (some 16% of infection-cases).
At the same time, stakeholders from all elements of the ‘whole patient pathway’ (hospitals, community-health and the care sector) must also now co-ordinate their crucial contribution to the UK Government’s five-year action plan and 20-year vision for tackling antimicrobial resistance (AMR). Key targets include reducing drug-resistant infections by 10% by 2025, reducing antibiotic use in humans by 15%, and reducing gram-negative blood-stream-infections.
In Birmingham, in February 2020, together with over 500 colleagues from across the “whole health economy”, experts will review the CQUIN results and discuss what progress is required to deliver the “Long Term Plan” targets in Infection Prevention & Control. The conference programme will review the new structures and working group initiatives of NHS England and Public Health England.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Register
